Curative Biotechnology Inc (CUBT)

$0.01 0.00 (-1.96%)
Market Cap 10.33M
Revenue (ttm) 0.00
Net Income (ttm) -5.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 21,200
Avg Vol 162,292
Day's Range N/A - N/A
Shares Out 1.01B
Stochastic %K 43%
Beta 0.20
Analysts Strong Buy
Price Target N/A

Company Profile

Curative Biotechnology, Inc., a development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices for patients with rare diseases. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504 a novel immune therapy to treat late-stage rabies;...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 907 8990
Address:
3801 PGA Blvd, Suite 600, Palm Beach Gardens, United States
Realistxxx
Realistxxx Aug. 11 at 8:25 PM
$CUBT something finally happening here?
1 · Reply
Austero
Austero Aug. 8 at 4:48 PM
$CUBT Hey CEO! How about a Press Release… Been over a year…
1 · Reply
Austero
Austero Aug. 8 at 4:45 PM
$CUBT Anyone know if they still have the same CEO Richard Garr?
1 · Reply
rednod6
rednod6 Aug. 1 at 10:09 PM
$CUBT https://www.sec.gov/ix?doc=/Archives/edgar/data/0001400271/000164117225021895/forms-1a.htm
1 · Reply
Realistxxx
Realistxxx Jul. 31 at 11:52 AM
$CUBT just another year of zero news from this company. Worst management ever.
0 · Reply
Austero
Austero Jul. 23 at 8:36 PM
$CUBT https://fighting-blindness-dot-org.s3.amazonaws.com/fc3p82cgqxfibiadrhrouhno2tpf?response-content-disposition=inline%3B%20filename%3D%22Eye%20on%20the%20Cure%20Podcast%20%20Episode%2064%20Dr.%20Kapil%20Bharti.pdf%22%3B%20filename%2A%3DUTF-8%27%27Eye%2520on%2520the%2520Cure%2520Podcast%2520%2520Episode%252064%2520Dr.%2520Kapil%2520Bharti.pdf&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAIZQ4HBPK4TAKDHGA%2F20250723%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20250723T203552Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=56ffa73821f15d3f8a1ccdbbfac68726eecdb99a23a6bb2dba19cf6a28531f2c
0 · Reply
Austero
Austero Jul. 23 at 8:35 PM
$CUBT 2025 excerpt from April 2024… hoping for some news soon
1 · Reply
Realistxxx
Realistxxx Jul. 17 at 5:19 PM
$CUBT how does this move so much on a meager volume trade? What is with this company? I had high hopes but may need to cut my losses.
1 · Reply
Billy_D
Billy_D Jul. 15 at 2:40 PM
$CUBT Not looking good 😕
0 · Reply
Realistxxx
Realistxxx Jul. 10 at 5:57 PM
$CUBT why is there NEVER news on this stock? Worst IR department and management team of all time.
1 · Reply
Latest News on CUBT
No data available.
Realistxxx
Realistxxx Aug. 11 at 8:25 PM
$CUBT something finally happening here?
1 · Reply
Austero
Austero Aug. 8 at 4:48 PM
$CUBT Hey CEO! How about a Press Release… Been over a year…
1 · Reply
Austero
Austero Aug. 8 at 4:45 PM
$CUBT Anyone know if they still have the same CEO Richard Garr?
1 · Reply
rednod6
rednod6 Aug. 1 at 10:09 PM
$CUBT https://www.sec.gov/ix?doc=/Archives/edgar/data/0001400271/000164117225021895/forms-1a.htm
1 · Reply
Realistxxx
Realistxxx Jul. 31 at 11:52 AM
$CUBT just another year of zero news from this company. Worst management ever.
0 · Reply
Austero
Austero Jul. 23 at 8:36 PM
$CUBT https://fighting-blindness-dot-org.s3.amazonaws.com/fc3p82cgqxfibiadrhrouhno2tpf?response-content-disposition=inline%3B%20filename%3D%22Eye%20on%20the%20Cure%20Podcast%20%20Episode%2064%20Dr.%20Kapil%20Bharti.pdf%22%3B%20filename%2A%3DUTF-8%27%27Eye%2520on%2520the%2520Cure%2520Podcast%2520%2520Episode%252064%2520Dr.%2520Kapil%2520Bharti.pdf&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAIZQ4HBPK4TAKDHGA%2F20250723%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20250723T203552Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=56ffa73821f15d3f8a1ccdbbfac68726eecdb99a23a6bb2dba19cf6a28531f2c
0 · Reply
Austero
Austero Jul. 23 at 8:35 PM
$CUBT 2025 excerpt from April 2024… hoping for some news soon
1 · Reply
Realistxxx
Realistxxx Jul. 17 at 5:19 PM
$CUBT how does this move so much on a meager volume trade? What is with this company? I had high hopes but may need to cut my losses.
1 · Reply
Billy_D
Billy_D Jul. 15 at 2:40 PM
$CUBT Not looking good 😕
0 · Reply
Realistxxx
Realistxxx Jul. 10 at 5:57 PM
$CUBT why is there NEVER news on this stock? Worst IR department and management team of all time.
1 · Reply
Finanz
Finanz May. 20 at 3:44 PM
$CUBT With a parent suffering from Macular Degeneration, I hope there is a eye drop treatment instead of the eye injections she goes through. With my risk of getting AMD, thee sooner the better https://www.openaccessgovernment.org/understanding-age-related-macular-degeneration-and-emerging-treatments/192782/
0 · Reply
Billy_D
Billy_D May. 6 at 2:05 PM
$CUBT
1 · Reply
Chinga77
Chinga77 Mar. 20 at 4:37 PM
$CUBT this company is such a scam did they renew the Corda because the original term it’s already over, just a bunch of you know who’s running this company and stealing from retail
1 · Reply
DancersDaddy
DancersDaddy Mar. 11 at 11:50 PM
$CUBT showing Olympic strength as the world around crumbles.
0 · Reply
Billy_D
Billy_D Mar. 11 at 3:34 PM
$CUBT
0 · Reply
Finanz
Finanz Mar. 7 at 2:55 PM
$CUBT "...for their first indications, intermediate dry AMD and Geographic Atrophy (late stage dry AMD), markets of unmet medical needs worldwide. The NEI will pay for the clinical trial moving forward under an existing CRADA (cooperative research and development agreement) with the Company. Curative is preparing to finalize their GMP manufacturing to produce the drugs for the trials." Such low volume, but creeping up ....
0 · Reply
rednod6
rednod6 Mar. 7 at 2:52 PM
$CUBT https://forcefamilyoffice.com/events/healthcare/curative-coming-march-26-2025/
0 · Reply
Finanz
Finanz Mar. 7 at 2:48 PM
$CUBT Looks like they are gearing up for moving forward. "Curative Biotechnology is developing a potential breakthrough treatment for degenerative eye disease. Unlike current treatments which require ocular injections, Curative has developed a reformulated version of the FDA-approved drug metformin to treat various types of retinal degeneration under an exclusive worldwide license from the National Eye Institute (NEI) at the NIH. Metformin has been shown to suppress oxidative stress, improve autophagy in retinal cells, decrease the production of reactive oxygen species that can lead to cell death, and inhibit the epithelial to mesenchymal transition which causes subretinal fibrosis in Dry AMD (age related macular degeneration). Unlike current treatments which require ocular injections, Curative has developed an eye drop which it believes can get sufficient drug to the back of the eye with topical application to have therapeutic effect. Curative is preparing for clinical trials...
0 · Reply
bt_overdrive
bt_overdrive Mar. 7 at 1:32 PM
$CUBT webinar soon obviously. https://forcefamilyoffice.com/events/healthcare/curative-coming-march-26-2025/
0 · Reply
Austero
Austero Feb. 21 at 4:29 PM
$CUBT Interviewer of vimeo is legit. https://forcefamilyoffice.com/our-team/
0 · Reply
Austero
Austero Feb. 20 at 7:27 PM
$CUBT https://vimeo.com/1056787047 $TAK Mentioned. 🎰 buy a lotto ticket!
1 · Reply
rednod6
rednod6 Feb. 14 at 10:11 PM
$CUBT https://vimeo.com/1056787047
0 · Reply